Mukka Proteins Limited
NSE: MUKKAAnimal FeedTrade-to-trade true
Share price
₹26.27
-0.45% close of 9 Oct 2026
Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 8 Oct 2026, the close above is 9 Oct 2026.
Business score
How strong the business is, in one number. The parts behind it are in Pro.
59
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹788 Cr
P/E ratio
11.3
P/B ratio
1.6
ROCE
11.6%
ROE
11.1%
Dividend yield
0.0%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Sales grew 76.0% over the past year, and 1.8% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 8.9% to 8.4% over the last two years.
Whether it grew faster than its sector
It grew 1.8% a year against a sector median of 9.9% — 8.1 percentage points slower.
Room to re-rate, or risk of de-rating
Too little price history yet to compare it with its own past.
Whether growth justifies the valuation
Priced at 1.9 times its growth rate, on earnings growth of 6%.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| Mukka Proteins Limited — this one | 6%/yr | 11.3× | ₹1.9 |
| Godrej Agrovet Limited | 23%/yr | 25.7× | ₹1.1 |
| Avanti Feeds Limited | 28%/yr | 18.2× | ₹0.65 |
| KSE Limited | 191%/yr | 11.4× | — |
| Narmada Agrobase Limited | 81%/yr | 23.5× | ₹0.29 |
| Ajooni Biotech Limited | 51%/yr | 13.0× | ₹0.26 |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies the exchange files under the same label (Animal Feed), it ranks 4 of 6 on returns, 6 of 6 on growth, 3 of 6 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
No durable advantage shows in the numbers: it earns 11.6% on capital, ahead of 33% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
No — Over the last five years the business itself consumed ₹424 crore of cash before any plant spend, funded mostly borrowed — borrowings rose from ₹175 crore to ₹779 crore. And the profit is not backed by cash: it reported a profit over 8 years and consumed cash from the business. Its cash comes back more slowly than it used to: it went from being paid 1 days before it paid its own suppliers to waiting 45 days for its cash.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
7 of 9 checks clear · 78%
Latest result · Q1 FY27
What the last results showed. Whether management kept its word is in Pro.
Announced 12 Aug 2026 · Consolidated · Unaudited
Revenue
₹490 Cr
Revenue vs last year
+186.3%
Revenue vs last quarter
+28.5%
Net profit
₹19 Cr
Profit vs last year
+831.7%
Profit vs last quarter
-11.3%
Net margin
3.8%
EPS
₹0.63
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹788 Cr
- Prev close
- ₹26.27
- 52w High
- ₹33.3
- 52w Low
- ₹18.3
- Enterprise value
- ₹1,507 Cr
- Beta
- 1.0
- Price CAGR 1y
- 2.0%
- Price CAGR 3y
- —
- Price CAGR 5y
- —
- Price CAGR 10y
- —
Ratios
- Return on assets
- 3.5%
- PEG ratio
- 1.9
- P/E ratio
- 11.3
- P/B ratio
- 1.6
- EV / EBITDA
- 10.3
- Industry P/E
- 15.5
- ROCE
- 11.6%
- ROCE 5y average
- 17.0%
- ROE
- 11.1%
- Debt / Equity
- 1.6
- Interest coverage
- 2.4
- Dividend yield
- 0.0%
- ROE 3y average
- 14.0%
- ROE last year
- 11.0%
Annual P&L
- Annual revenue
- ₹1,449 Cr
- Annual profit
- ₹57 Cr
- Operating margin
- 8.0%
- Net profit margin
- 3.9%
- EBITDA margin
- 7.9%
- Sales growth 3y
- 7.2%
- Sales growth 5y
- 19.1%
- Profit growth 3y
- 6.0%
- Profit growth 5y
- 53.0%
- EPS
- ₹1.7
- Sales growth TTM
- 76.0%
- Profit growth TTM
- 59.0%
- Dividend payout
- 0.0%
Quarter P&L
- Sales latest quarter
- ₹490 Cr
- Profit latest quarter
- ₹19 Cr
- YoY quarterly sales growth
- 186.7%
- YoY quarterly profit growth
- 850.0%
- OPM latest quarter
- 9.6%
Balance Sheet
- Book Value
- ₹16.6
- Face Value
- ₹1.0
- Total debt
- ₹779 Cr
- Total cash
- ₹60 Cr
- Borrowings
- ₹779 Cr
- Reserves / Equity
- 15.6
Cash Flow
- Operating cash flow
- -₹111 Cr
- Free cash flow
- -₹248 Cr
- FCF yield
- -38.2%
- Net cash flow
- ₹10 Cr
Shareholding
- Promoter holding
- 73.3%
- FII holding
- 1.7%
- DII holding
- 0.0%
- Public holding
- 24.9%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| Godrej Agrovet | 630.15 | 25.8 | 12,125 | 1.75 | 128.3 | -16.2 | 2,855.2 | 9.2 | 19.2 |
| Avanti Feeds | 709.60 | 17.9 | 9,668 | 1.39 | 116.3 | -42.0 | 1,899.9 | 18.3 | 24.4 |
| Mukka Proteins | 26.50 | 11.5 | 795 | 0.00 | 18.6 | 1142.8 | 489.7 | 186.7 | 11.6 |
| KSE | 176.80 | 12.3 | 566 | 7.07 | 0.9 | -98.4 | 453.7 | 9.1 | 33.5 |
| Shivam Chemicals | 146.90 | 41.7 | 250 | 0.00 | 4.2 | 163.9 | 152.6 | 17.6 | 16.6 |
| Mayank Cattle Fo | 101.00 | 18.1 | 109 | 0.00 | 3.5 | 18.3 | 217.8 | 2.9 | 15.8 |
| Narmada Agrobase | 11.31 | 23.9 | 86 | 0.00 | 0.8 | -26.5 | 22.3 | 100.9 | 8.9 |
| Median | 161.85 | 18.0 | 680 | 0.69 | 11.4 | 1.1 | 471.7 | 13.4 | 17.9 |
Competes with: Ajooni Biotech Limited, Avanti Feeds Limited, Godrej Agrovet Limited, KSE Limited, Narmada Agrobase Limited
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274 | 332 | 517 | 257 | 173 | 149 | 303 | 382 | 171 | 245 | 654 | 381 | 490 |
| Expenses | 260 | 294 | 498 | 224 | 159 | 140 | 262 | 352 | 157 | 224 | 608 | 347 | 443 |
| Material Cost | 193 | 280 | 582 | 375 | 392 | ||||||||
| Change in Inventories | -64 | -92 | -31 | -75 | -10 | ||||||||
| Purchases of Stock-in-Trade | 0 | 0 | 0 | 0 | 0 | ||||||||
| Employee Cost | 7.89 | 8.94 | 11 | 13 | 16 | ||||||||
| Other Expenses | 19 | 26 | 46 | 33 | 43 | ||||||||
| Operating Profit | 14 | 38 | 19 | 32 | 14 | 10 | 41 | 29 | 14 | 20 | 45 | 34 | 47 |
| OPM % | 5.24 | 11 | 3.65 | 13 | 8.08 | 6.41 | 14 | 7.62 | 8.26 | 8.29 | 6.95 | 8.90 | 9.60 |
| Other Income | 3 | 6 | 8 | 5 | 3 | 4 | 6 | 4 | 3 | 6 | 8 | 15 | 2 |
| Exceptional items (within Other Income) | 0 | 0 | 0 | 0 | 0 | ||||||||
| Interest | 6 | 6 | 6 | 7 | 8 | 9 | 11 | 10 | 11 | 13 | 15 | 15 | 16 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 5 |
| Profit before tax | 8 | 35 | 17 | 27 | 6 | 1 | 33 | 20 | 2 | 9 | 35 | 29 | 27 |
| Tax % | 45 | 18 | 31 | -8 | 5 | -40 | 19 | 30 | 33 | 26 | 21 | 26 | 32 |
| Net Profit | 4 | 29 | 12 | 29 | 5 | 1 | 27 | 14 | 2 | 7 | 27 | 21 | 19 |
| EPS in Rs | 0.16 | 1.28 | 0.48 | 0.91 | 0.14 | 0.07 | 0.88 | 0.45 | 0.05 | 0.20 | 0.79 | 0.69 | 0.63 |
| Diluted EPS in Rs | 0.05 | 0.20 | 0.79 | 0.69 | 0.63 |
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 409 | 549 | 604 | 770 | 1,177 | 1,380 | 1,006 | 1,449 | 1,768 |
| Expenses | 385 | 525 | 582 | 723 | 1,091 | 1,274 | 912 | 1,335 | 1,622 |
| Material Cost | 1,431 | ||||||||
| Change in Inventories | -261 | ||||||||
| Purchases of Stock-in-Trade | 0 | ||||||||
| Employee Cost | 41 | ||||||||
| Other Expenses | 125 | ||||||||
| Operating Profit | 23 | 24 | 22 | 48 | 86 | 105 | 95 | 115 | 147 |
| OPM % | 6 | 4.30 | 3.60 | 6 | 7 | 8 | 9 | 8 | 8 |
| Other Income | 2 | 8 | 10 | 7 | 8 | 19 | 16 | 31 | 31 |
| Exceptional items (within Other Income) | 0 | ||||||||
| Interest | 4 | 7 | 8 | 10 | 16 | 25 | 37 | 54 | 59 |
| Depreciation | 2 | 5 | 8 | 9 | 12 | 12 | 14 | 17 | 18 |
| Profit before tax | 19 | 20 | 15 | 36 | 66 | 87 | 60 | 75 | 100 |
| Tax % | 27 | 31 | 29 | 28 | 28 | 15 | 20 | 24 | |
| Net Profit | 14 | 14 | 11 | 26 | 48 | 74 | 48 | 57 | 74 |
| EPS in Rs | 1.10 | 2 | 2.34 | 1.55 | 1.74 | 2.31 | |||
| Diluted EPS in Rs | 1.74 | ||||||||
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- —
- 5 years
- 19%
- 3 years
- 7%
- TTM
- 76%
Compounded profit growth
- 10 years
- —
- 5 years
- 53%
- 3 years
- 6%
- TTM
- 59%
Stock price CAGR
- 10 years
- —
- 5 years
- —
- 3 years
- —
- 1 year
- 2%
Return on equity
- 10 years
- —
- 5 years
- 17%
- 3 years
- 14%
- Last year
- 11%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 22 | 22 | 30 | 30 | 30 |
| Reserves | 38 | 51 | 61 | 76 | 126 | 366 | 411 | 469 |
| Borrowings | 83 | 142 | 159 | 175 | 262 | 365 | 453 | 779 |
| Other Liabilities | 74 | 95 | 129 | 119 | 166 | 179 | 183 | 343 |
| Minority Interest | 30 | |||||||
| Total Liabilities | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
| Fixed Assets | 49 | 78 | 79 | 83 | 85 | 85 | 94 | 194 |
| CWIP | 0 | 2 | 4 | 0 | 0 | 0 | 9 | 31 |
| Investments | 8 | 4 | 12 | 21 | 21 | 31 | 37 | 56 |
| Other Assets | 144 | 209 | 260 | 289 | 469 | 825 | 937 | 1,341 |
| Total Assets | 201 | 293 | 355 | 392 | 575 | 941 | 1,076 | 1,621 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -20 | -25 | 2 | 5 | -56 | -150 | -112 | -111 |
| Cash from Investing Activity | -23 | -28 | -14 | -11 | -3 | -48 | -35 | -146 |
| Cash from Financing Activity | 34 | 54 | 13 | 15 | 75 | 266 | 56 | 267 |
| Net Cash Flow | -9 | 1 | 2 | 8 | 15 | 68 | -91 | 10 |
| Free Cash Flow | -39 | -61 | -8 | -1 | -64 | -165 | -135 | -247 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 23 | 29 | 29 | 35 | 49 | 72 | 46 |
| Inventory Days | 95 | 89 | 106 | 95 | 89 | 136 | 266 | 267 |
| Days Payable | 63 | 63 | 71 | 56 | 51 | 44 | 67 | 75 |
| Cash Conversion Cycle | 57 | 49 | 64 | 68 | 73 | 141 | 272 | 238 |
| Working Capital Days | 4 | -9 | -12 | -1 | 10 | 45 | 99 | 45 |
| ROCE % | 15 | 9 | 18 | 24 | 19 | 12 | 12 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash
719inr_cr
2026-03-31
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-03-31
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-03-31
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-03-31
News
News and filings about Mukka Proteins Limited. Open one to see why it matters.
10 Sept, 18:05 IST · Company event · medium impact
Mukka Proteins Limited — allotment of 20000000 securities pursuant to Preferential Issue at its circular resolution dated September 09, 2026.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Uses as raw material
- black soldier fly larvae reared on organic waste (BSF meal/oil/frass line)
- raw fish (sardines, mackerel, anchovy and other pelagic catch)
- seafood processing by-products / fish trimmings
Depends on the price of
- Seafood
Sells to
- Avanti Feeds Limited · fish meal and fish oil for aqua feed; Rs 31.77 cr purchase order Mar-2025 + Rs 152.5 mn fi…
- Padma Feed & Chicks · fish meal; USD 220,000 purchase order Mar-2025
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Fast Moving Consumer Goods
- Industry
- Animal Feed
- Classification
- Fast Moving Consumer Goods › Animal Feed
- ISIN
- INE0CG401037
Plants
- Atlantic Marine Products plant, Mitiyala
- Bagalur unit
- Baleswar tie-up facility
- FABBCO unit, Kakkanad
- GSM Marine Exports unit, Mangrol
- HRC Jathin Ecosolutions BSF unit, Bidarahalli
- Ocean Aquatic Proteins LLC plant, Shinas
- Pacific Marine Products unit, Veraval
- Progress Frozen and Fish Sterilization unit, Porbandar
- Surathkal fish meal and oil plant
- Ullal fish meal and oil plant
News impact
Big market events that reach Mukka Proteins Limited, and how the effect spreads.
No recent market events reach this company.
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Splits, bonuses & buybacks
- daily-prices repair: 4 rows from NSE's archive (replace 1, delete 1, insert 2), 2024-05-18..2026-02-01 (docs/flat_day_repair.md)1× · 18 May 2024
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Annual report · 2025-2618 Aug 2026
- Results presentation30 Jun 2026
- Annual report · 2024-2526 Aug 2025
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.